Skip to main content
HeartCited

Quercetin für Atherosclerosis

D Forschung Es existiert nur vorläufige Forschung (Laborstudien, Fallberichte).

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

D

Fazit

In vitro evidence for PCSK9 inhibition and reduced foam cell formation. Limited human data on atherosclerosis endpoints specifically.

Key Statistics

2

Studien

100

Teilnehmer

↑

Positive

D

Bewertung

Referenced Papers

Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based … Other
Current computer-aided drug … 2025 2 Zitierungen
Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin … Other
Iranian journal of … 2024 4 Zitierungen
Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease. Review
Pharmacological research 2019 31 Zitierungen
Dietary Polyphenols in the Prevention of Stroke. Review
Oxidative medicine and … 2017 87 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
500-1,000 mg/day
bloodpressuresupport:
500-730 mg/day

Obergrenze: Not formally established; up to 1,000 mg/day used in clinical trials

Beste Einnahmezeit: With meals; vitamin C co-supplementation may enhance bioavailability

Safety & Side Effects

Gemeldete Nebenwirkungen

  • ⚠ Generally well-tolerated
  • ⚠ Headache (rare)
  • ⚠ Mild gastrointestinal discomfort
  • ⚠ Tingling in extremities (rare, high doses)

Bekannte Wechselwirkungen

  • ● Antibiotics (quinolones — may reduce efficacy)
  • ● Cyclosporine (may increase blood levels)
  • ● Anticoagulants (may have mild antiplatelet effect)
  • ● Blood pressure medications (additive effect)

Tolerierbare Höchstaufnahmemenge: Not formally established; up to 1,000 mg/day used in clinical trials

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Quercetin help with Atherosclerosis?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Quercetin may support Atherosclerosis management. Our evidence grade is D (Very Early Research).
How much Quercetin should I take for Atherosclerosis?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Quercetin?
Reported side effects may include Generally well-tolerated, Headache (rare), Mild gastrointestinal discomfort, Tingling in extremities (rare, high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Quercetin and Atherosclerosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Quercetin für andere Beschwerden

High Blood Pressure (Hypertension) B

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  










  
References

  
    
    
    
  1. 
      [1]
      Sihong Huang et al..
      Curr Comput Aided Drug Des.
      2025.
      Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based …
      doi:10.2174/0115734099299714240516160158
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Masoumeh Shamsi et al..
      Iran J Pharm Res.
      2024.
      Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin …
      doi:10.5812/ijpr-151428
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Wang Anlu et al..
      Pharmacol Res.
      2019.
      Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease.
      doi:10.1016/j.phrs.2019.02.018
      PubMed
    
    4. 
    
    
  4. 
      [4]
      A Tressera-Rimbau et al..
      Oxid Med Cell Longev.
      2017.
      Dietary Polyphenols in the Prevention of Stroke.
      doi:10.1155/2017/7467962
      PubMed
    
    5. 
    
  















    

        FDA-Haftungsausschluss:
        Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.